Genzhou Liu Selected Research

tyloxapol drug combination hexadecanol dipalmitoylphosphatidylcholine (Exosurf Neonatal)

6/2007

One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Genzhou Liu Research Topics

Disease

5	Congenital Abnormalities (Deformity) 01/2020 - 01/2015
4	Cellulite 05/2022 - 01/2019
4	Penile Induration (Peyronie's Disease) 01/2020 - 01/2015
1	Bronchopulmonary Dysplasia 01/2009
1	Pneumonia (Pneumonitis) 01/2009
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 06/2007

Drug/Important Bio-Agent (IBA)

8	Microbial Collagenase (Clostridiopeptidase A)FDA Link 05/2022 - 01/2015
2	CollagenIBA 05/2022 - 01/2019
2	Peptides (Polypeptides)IBA 01/2009 - 06/2007
2	lucinactantIBA 01/2009 - 06/2007
2	Surface-Active Agents (Surfactants)IBA 01/2009 - 06/2007
1	propylene diquat (PDQ(+))IBA 11/2017
1	Pharmaceutical PreparationsIBA 01/2015
1	Oxidants (Oxidizing Agents)IBA 01/2009
1	Oxygen (Dioxygen)IBA 01/2009
1	tyloxapol drug combination hexadecanol dipalmitoylphosphatidylcholine (Exosurf Neonatal)FDA Link 06/2007

Therapy/Procedure

3	Therapeutics 11/2017 - 06/2007
2	Injections 01/2019 - 08/2017
1	Aftercare (After-Treatment) 12/2020
1	Intralesional Injections 01/2015